Quantcast

Latest Novira Therapeutics Inc. Stories

2014-08-26 08:30:57

DOYLESTOWN, Pa., Aug. 26, 2014 /PRNewswire/ -- Novira Therapeutics, Inc., a privately held biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection, today announced that Roger J. Pomerantz, M.D., F.A.C.P., was appointed the Chair of its Scientific Advisory Board (SAB). In this role he will also function as a Senior Advisor to the Company. "We are thrilled to have Roger join our SAB as Chair," said Christian Schade,...

2014-05-08 08:32:52

DOYLESTOWN, Pa., May 8, 2014 /PRNewswire/ -- Novira Therapeutics, Inc., a privately held biopharmaceutical company developing novel therapies for curative treatment of chronic hepatitis B virus (HBV) infection, today announced that it initiated a Phase 1a clinical study of NVR-1221. The Phase 1a clinical study is designed to assess the pharmacokinetic profile and dose-related safety and tolerability of NVR-1221 in healthy volunteers. "We are thrilled to begin the clinical development...

2014-03-19 08:29:01

DOYLESTOWN, Pa., March 19, 2014 /PRNewswire/ -- Novira Therapeutics, Inc., today announced that Christian S. Schade has been named Chief Executive Officer, effective March 19. Mr. Schade has more than 30 years of extensive private and public pharmaceutical and biotechnology industry experience as well as broad capital markets experience from his tenure in the investment banking industry. Prior to joining Novira he was Executive Vice President and Chief Financial Officer of Omthera...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related